DYDASK
DYDASK is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show negative equity (€-1k) and a net result of €-2k. The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-1k |
| Net result | €-2k |
| Active | 0 yrs |
| Locations | 1 |
Mixed profile: strong on profitability, weaker on health.
This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €-2k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €998 |
| Equity | €-1k |
| Debt | €2k |
| of which ≤ 1y | €2k |
| of which > 1y | - |
| Working capital | €-1k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 0.41 |
| Quick ratio | 0.41 |
| Working capital ratio | -144.8% |
| Solvency | -144.8% |
| Debt / equity | -1.69 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -245.1% |
| ROE | 169.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €998 |
| Current assets | 29/58 | €998 |
| Cash & bank | 54/58 | €998 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €998 |
| Equity | 10/15 | €-1k |
| Contributions / capital | 10/11 | €1k |
| Accumulated profits (losses) | 14 | €-2k |
| Amounts payable | 17/49 | €2k |
| Amounts payable within one year | 42/48 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €-2k |
| Operating result | 9901 | €-2k |
| Financial charges | 65 | €3 |
| Result before taxes | 9903 | €-2k |
| Net result for the period | 9904 | €-2k |
| Result to be appropriated | 9905 | €-2k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 23-12-2025 |
| Status | Active |
| Postal code | 1160 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21332B0260/00D002 | Brussels | 339 m² | 1 · 153 m² | 15.9 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
29-12-2025 Incorporation of a new SRL
Technical details
{
"notary": {
"name": "C\u00E9cile FRANCOIS",
"firm_city": null,
"firm_name": "FRANCOIS C\u00E9cile soci\u00E9t\u00E9 notariale",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2025-12-29",
"filing_date": "2025-12-23",
"act_kind_objet": "Objet de l\u0027acte:",
"is_private_deed": false
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-12-18",
"unanimous": true
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1991-06-25",
"name": "Oullai Ali",
"niss": null,
"address": "1040 Bruxelles, avenue Jules Malou, 59",
"nationality": "France",
"place_of_birth": "Ivry-sur-Seine, France"
},
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1000.0,
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 1000.0,
"is_anonymous_silent_partner": false
}
],
"voorwerp": {
"full_text": "La soci\u00E9t\u00E9 a pour objet l\u0027exercice de l\u0027art de gu\u00E9rir, et plus pr\u00E9cis\u00E9ment dans le cadre de la n\u00E9phrologie qui consiste en un diagnostic et traitement de pathologies li\u00E9s \u00E0 la sp\u00E9cialisation m\u00E9dicale, en ce compris des consultations, suivi des patients, ainsi tout acte technique propre \u00E0 la profession m\u00E9dicale, et toute mesure pr\u00E9ventive. En compl\u00E9ment \u00E0 ces premi\u00E8res activit\u00E9s, il proc\u00E9dera \u00E0 tout traitement chirurgical de pathologies de la sph\u00E8re n\u00E9phrologie diagnostiqu\u00E9es en consultation ou aux urgences hospitali\u00E8res si cela s\u0027av\u00E8re n\u00E9cessaire. Il travaillera en \u00E9troite collaboration avec d\u0027autres sp\u00E9cialistes comme les urologues, les cardiologues et les m\u00E9decins g\u00E9n\u00E9ralistes. Cet objet comprend la mise \u00E0 disposition des moyens n\u00E9cessaires aux m\u00E9decins pour exercer leur art au sein de la soci\u00E9t\u00E9. La soci\u00E9t\u00E9 pourra proc\u00E9der \u00E0 toutes les recherches et toutes \u00E9tudes en rapport avec son objet principal, s\u0027occuper de la recherche et du d\u00E9veloppement de techniques scientifiques favorisant un diagnostic pr\u00E9cis. Elle pourra dispenser tous avis, donner tous cours et conf\u00E9rences et organiser tous s\u00E9minaires dans le cadre de la pratique m\u00E9dicale. La soci\u00E9t\u00E9 pourra, en Belgique, exercer toute autre activit\u00E9 susceptible de favoriser son objet, tant en mati\u00E8re ind\u00E9pendante que dans le cadre de contrats avec des \u00E9tablissements de soins ou des confr\u00E8res m\u00E9decins, dans le respect du Code de D\u00E9ontologie M\u00E9dicale. La soci\u00E9t\u00E9 pourra \u00E9galement, s\u0027int\u00E9resser de toutes fa\u00E7ons dans toutes soci\u00E9t\u00E9s ou entreprises existantes ou \u00E0 cr\u00E9er, dont l\u0027objet serait similaire, analogue ou connexe au sien. La soci\u00E9t\u00E9 pourra poser tout acte n\u00E9cessaire et/ou indispensable \u00E0 l\u0027accomplissement de son objet et plus particuli\u00E8rement toute transaction mobili\u00E8re ou immobili\u00E8re ou de valorisation de patrimoine immobilier concernant les locaux m\u00E9dicaux, l\u0027achat du mat\u00E9riel m\u00E9dical et non m\u00E9dical, l\u0027engagement du personnel administratif, soignant, pratiquant ou appel\u00E9 \u00E0 pratiquer dans la soci\u00E9t\u00E9. La soci\u00E9t\u00E9 pourra d\u0027une fa\u00E7on g\u00E9n\u00E9rale accomplir toutes op\u00E9rations se rapportant directement ou indirectement \u00E0 la r\u00E9alisation de son objet, sans en modifier la vocation m\u00E9dicale. La soci\u00E9t\u00E9 garantit \u00E0 chaque m\u00E9decin associ\u00E9 qu\u0027il pourra exercer sa profession en tout ind\u00E9pendance dans le respect des r\u00E8gles relatives au secret m\u00E9dical, \u00E0 la libert\u00E9 diagnostique et th\u00E9rapeutique, et au libre choix du patient. Toute forme de commercialisation de la m\u00E9decine, de collusion directe ou indirecte, de dichotomie et de surconsommation est exclue. A titre accessoire, la soci\u00E9t\u00E9 pourra accomplir toutes op\u00E9rations immobili\u00E8res, mobili\u00E8res, financi\u00E8res : en respectant la d\u00E9ontologie m\u00E9dicale et pour autant que ces op\u00E9rations s\u0027inscrivent dans les limites, d\u0027une gestion en \u00AB bon p\u00E8re de famille \u00BB n\u0027aient pas un caract\u00E8re r\u00E9p\u00E9titif et/ou commercial.",
"is_lucrative": true,
"short_summary": "Exercice de la m\u00E9decine sp\u00E9cialis\u00E9e en n\u00E9phrologie, y compris diagnostic, traitement, chirurgie, collaboration m\u00E9dicale et recherche scientifique."
},
"governance": {
"organ_kind": "enige_bestuurder",
"n_directors_max": 1,
"n_directors_min": 1,
"representation_clause": "enige bestuurder alleen",
"co_signature_threshold_eur": null
},
"fiscal_year": {
"end_mm_dd": "12-31",
"start_mm_dd": "01-01",
"first_exercise_end_date": "2025-12-31",
"is_prolonged_first_exercise": false
},
"agm_schedule": {
"time": "18:00",
"month": 6,
"rule_text": "premier lundi du mois de juin"
},
"founding_event": {
"n_shares_total": 100,
"n_share_classes": 1,
"bank_attestation": {
"date": "2025-12-05",
"bank_name": "Banque (...)",
"amount_eur": 1000.0,
"iban_masked": null
},
"amount_paid_in_eur": 1000.0,
"incorporation_date": "2025-12-18",
"amount_subscribed_eur": 1000.0,
"art_5_8_no_payment_due": false,
"pre_incorporation_activity_from_date": "2025-10-01"
},
"subject_company": {
"kbo": "1032.155.323",
"email": null,
"region": "brussels_hoofdstedelijk_gewest",
"website": null,
"name_full": "DYDASK",
"legal_form": "SRL",
"name_abbreviated": null,
"zetel_address_raw": "1160 Auderghem, Rue Emile Idiers, 13",
"equity_account_type": "unavailable",
"_kbo_filled_from_list": true
},
"initial_directors": [
{
"kind": "natural_person",
"person": {
"name": "Oullai Ali",
"address": "1040 Bruxelles, avenue Jules Malou, 59"
},
"via_org": null,
"role_sub": "enige_bestuurder",
"mandate_until": {
"kind": "indefinite",
"value": null
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
}
],
"co_filed_documents": [
"expedition",
"statuten",
"plan financier",
"bankattest"
],
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | DYDASK |